missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Spartalizumab Recombinant Monoclonal Antibody
Recombinant Monoclonal Antibody
Marque: Invitrogen™ MA558364
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.
Spartalizumab (PDR001) is a humanized IgG4 monoclonal antibody that targets PD-1 with sub-nanomolar affinity to block its interaction with PD-L1/PD-L2, thereby preventing PD-1 mediated inhibitory signals Transduction leads to the activation of T cells.
Spécification
| Spartalizumab Humanized | |
| Recombinant Monoclonal | |
| Unconjugated | |
| NPVPDR001; NVS240118; PDR001 | |
| Protein A | |
| RUO | |
| Human | |
| Antibody | |
| IgG4SP |
| ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance | |
| 1 mg/mL | |
| 25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2 | |
| Human | |
| 1 mg | |
| Primary | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Lyophilized |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu